Welcome to our dedicated page for SFE news (Ticker: SFE), a resource for investors and traders seeking the latest updates and insights on SFE stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect SFE's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of SFE's position in the market.
Safeguard Scientifics (NYSE: SFE) will host a virtual discussion with John Nardone, CEO of Flashtalking, on September 16, 2020 at 10:00 a.m. ET. This event is aimed at providing shareholders with insights into Safeguard's ownership interests. Safeguard holds a 13.4% stake in Flashtalking, a leading ad management platform. Nardone, with over 30 years in advertising, has previously worked at major firms including Procter & Gamble. Participants can register for the event online and will have access to a replay thereafter.
Safeguard Scientifics (NYSE:SFE) announced its participation in the LD Micro 500 Virtual Conference scheduled for September 1-4, 2020. Key executives, Eric Salzman and Mark Herndon, will present and hold one-on-one meetings. The LD Micro Conference has hosted over 1,300 companies in 12 years, attracting significant institutional and retail investor interest. Safeguard focuses on value-maximizing strategies for its technology-driven investments and aims to enhance shareholder returns. More details can be found on safeguard.com.
Safeguard Scientifics reported Q2 2020 results with a net loss of $9.9 million, or $0.48 per share, contrasting with a net income of $36.1 million in Q2 2019. Follow-on funding totaled $4.4 million, including $3.8 million for Syapse. Year-to-date cash and equivalents stand at $13.6 million against total ownership interests valued at $61.4 million. General and Administrative expenses were reduced by 30% year over year. Safeguard anticipates follow-on funding requirements between $8-$12 million for the full year, with corporate expenses likely at the low end of previous projections.
Safeguard Scientifics (SFE) is set to release its financial results for the second quarter ending June 30, 2020, on August 11, 2020, before market open. The conference call will occur at 9:00 am ET, featuring key executives including Dr. Robert J. Rosenthal and Mark A. Herndon. Investors can access the webcast on the company's website. Replay options will be available until September 10, 2020.
Safeguard Scientifics (NYSE:SFE) announced a virtual discussion scheduled for July 30, 2020, featuring Jan Bruce, CEO of meQuilibrium. The session, led by Dr. Gary Kurtzman, aims to explore meQuilibrium's AI-driven resilience platform designed to enhance workforce agility and performance during crises like the COVID-19 pandemic. Participants can register for the event online, which will be available for replay afterwards on the company's investor relations website.
For further information, visit www.safeguard.com.